Mar. 15, 2024 | ZIPCODE CEO DR. JASON ZHANG TO PRESENT AT WORLD VACCINE CONGRESS WASHINGTON 2024

Boston, MA, USA - Zipcode Bio, a startup focusing on next-generation nucleic acid applications, has announced that its co-founder and CEO, Dr. Jason Zhang will present at the World Vaccine Congress this April 1st, in Washington D.C. As a seasoned professional in nucleic acid technologies, Dr. Zhang will present on the topic "From a preventive vaccine to a therapeutic vaccine", offering a glimpse into the future of RNA therapeutics.

Zipcode Bio leverages strong RNA knowledge and pioneering SHARP technology to craft innovative solutions aimed at redefining the development of RNA based medicines. The presentation will provide insight into cutting-edge research and Zipcode Bio’s commitment to developing revolutionary therapeutics.

For more information about the World Vaccine Congress Washington, please visit https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm

About Zipcode Bio: Zipcode Bio is a biotechnology company specializing in the development of next-generation nucleic acid applications that are accessible, widely distributable, and superior in efficacy and safety. The company's co-founders include Drew Weissman and Dr. Jason Zhang. The scientific strength is based on the co-founders’ deep knowledge in RNA medicine and breakthrough SHARP (Single-component Homogeneous Amphiphilic Routed Particles) technology. Zipcode Bio stands at the forefront of developing revolutionary solutions with the potential to transform patient care. The company has assembled a dynamic team committed to pushing scientific boundaries and developing novel therapeutics to address unmet healthcare needs. The dedication to innovation, precision, and accessibility underscores its mission to improve therapeutic outcomes and contribute to the evolution of global healthcare.